STOCK TITAN

Schedule 13D/A: Star Equity and Hudson Global Report 7.13% of GYRO, Nominate Two Directors

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Star Equity Fund and affiliated parties report beneficial ownership of 156,774 shares of Gyrodyne, LLC, representing approximately 7.13% of the outstanding common stock based on 2,199,308 shares outstanding as of August 8, 2025. The filing is Amendment No. 7 to a Schedule 13D and states the Reporting Persons filed jointly under a Joint Filing Agreement dated August 22, 2025. The group includes Star Equity Fund, Star Equity GP, Star Investment Management, Star Operating Companies, Star Value, Hudson Global, CEO Jeffrey E. Eberwein, and nominees Hannah M. Bible and Matthew R. Sullivan. The filing confirms sole voting and dispositive power over the 156,774 shares by the named reporting entities and discloses no recent transactions for most reporting persons within the past 60 days, with Star Equity Funds recent trades referenced in an attached Schedule A.

Positive

  • Reporting Persons disclose a clear, material stake of 156,774 shares (~7.13% of outstanding common stock)
  • Filing establishes a formal Joint Filing Agreement dated August 22, 2025, signaling coordinated action
  • Reporting Persons have nominated two individuals (Hannah M. Bible and Matthew R. Sullivan) for the issuers board, indicating active governance engagement
  • Filing states no criminal convictions or disqualifying civil judgments for reporting persons in the past five years

Negative

  • None.

Insights

TL;DR: A coordinated investor group now publicly holds ~7.13% of GYRO and has nominated two board candidates, a potentially influential stake though non-controlling.

The Schedule 13D/A discloses an aggregate 156,774-share position (7.13%) beneficially owned by Star-related entities and Hudson Global. The joint filing and the nomination of two director candidates signal an organized engagement with the companys governance. Sole voting and dispositive power are asserted by the reporting entities, indicating centralized control of the position. While 7.13% is below control thresholds, it is large enough to influence board composition or proxy contests if supported by other shareholders. The filing references recent transactions by Star Equity Fund in an attached Schedule A but does not detail trade dates or prices in this amendment.

TL;DR: Joint Schedule 13D and director nominations indicate active governance intent; material but not necessarily hostile or controlling.

The document formalizes a coordinated group owning 7.13% and confirms a Joint Filing Agreement dated August 22, 2025. Inclusion of nominees Hannah M. Bible and Matthew R. Sullivan demonstrates a move from passive ownership to direct governance engagement. The filing states sole voting and dispositive power for the reporting entities, which simplifies accountability and communication with the issuer. No litigation or regulatory issues are disclosed for the reporting persons. The annexed Schedule A and the Joint Filing Agreement (Exhibits 99.17 and 99.18) are material for further detail on timing and strategy but are referenced rather than reproduced here.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
The following constitutes Amendment No. 7 ("Amendment No.7") to the Schedule 13D filed by the undersigned on August 1, 2022 (as previously amended, the "Schedule 13D"). This Amendment No. 7 amends the Schedule 13D as specifically set forth herein.


SCHEDULE 13D


STAR EQUITY FUND, LP
Signature:/s/ Jeffrey E. Eberwein
Name/Title:Jeffrey E. Eberwein, Manager of Star Equity Fund GP, LLC, the general partner of Star Equity Fund LP
Date:08/26/2025
STAR EQUITY FUND GP, LLC
Signature:/s/ Jeffrey E. Eberwein
Name/Title:Jeffrey E. Eberwein, Manager
Date:08/26/2025
STAR INVESTMENT MANAGEMENT, LLC
Signature:/s/ Jeffrey E. Eberwein
Name/Title:Jeffrey E. Eberwein, Manager
Date:08/26/2025
STAR OPERATING COMPANIES, INC.
Signature:/s/ Richard K. Coleman, Jr.
Name/Title:Richard K. Coleman, Jr., Chief Executive Officer
Date:08/26/2025
HUDSON GLOBAL, INC.
Signature:/s/ Jeffrey E. Eberwein
Name/Title:Jeffrey E. Eberwein, Chief Executive Officer
Date:08/26/2025
JEFFREY E. EBERWEIN
Signature:/s/ Jeffrey E. Eberwein
Name/Title:Jeffrey E. Eberwein
Date:08/26/2025
STAR VALUE, LLC
Signature:/s/ Richard K. Coleman, Jr.
Name/Title:Richard K. Coleman, Jr., CEO of Star Operating Companies, Inc., the sole member of Star Value, LLC
Date:08/26/2025
HANNAH M. BIBLE
Signature:/s/ Hannah M. Bible
Name/Title:Hannah M. Bible
Date:08/26/2025
MATTHEW R. SULLIVAN
Signature:/s/ Matthew R. Sullivan
Name/Title:Matthew R. Sullivan
Date:08/26/2025

FAQ

What percentage of Gyrodyne (GYRO) does Star Equity Fund and affiliates own?

The Reporting Persons beneficially own 156,774 shares, approximately 7.13% of Gyrodyne's outstanding common stock based on 2,199,308 shares outstanding.

Who are the Reporting Persons named in the Schedule 13D/A for GYRO?

The Reporting Persons include Star Equity Fund, LP; Star Equity Fund GP, LLC; Star Investment Management, LLC; Star Operating Companies, Inc.; Star Value, LLC; Hudson Global, Inc.; Jeffrey E. Eberwein; and nominees Hannah M. Bible and Matthew R. Sullivan.

Does the filing indicate voting or disposition control over the shares?

Yes. The filing states the Reporting Persons have sole voting and sole dispositive power over the 156,774 shares.

Are there director nominees associated with this Schedule 13D/A for GYRO?

Yes. The filing identifies Hannah M. Bible and Matthew R. Sullivan as nominees for election to Gyrodyne's board of directors.

Does the filing disclose recent transactions by the Reporting Persons in GYRO shares?

Most Reporting Persons report no transactions in the past 60 days; transactions by Star Equity Fund in the last 60 days are referenced in Exhibit 99.17 (Schedule A) attached to the filing.

Are there any legal or regulatory disclosures about the Reporting Persons?

The filing states that no Reporting Person has been convicted of a crime (excluding minor offenses) or subject to certain adverse civil proceedings in the past five years.
Gyrodyne Llc

NASDAQ:GYRO

GYRO Rankings

GYRO Latest News

GYRO Latest SEC Filings

GYRO Stock Data

20.63M
1.50M
31.69%
36.79%
0.01%
Real Estate Services
Operators of Nonresidential Buildings
Link
United States
ST. JAMES